Quick Answer
CORCEPT THERAPEUTICS INC reported Operating Income of $44.80 million for fiscal year 2025.
CORCEPT THERAPEUTICS INC Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $44.80M | -67.3% |
| 2024 | $136.95M | +27.7% |
| 2023 | $107.28M | -4.8% |
| 2022 | $112.63M | -9.5% |
| 2021 | $124.48M | -2.9% |
| 2020 | $128.20M | +14.9% |
| 2019 | $111.61M | +24.7% |
| 2018 | $89.50M | +69.3% |
| 2017 | $52.85M | +419.3% |
| 2016 | $10.18M | +395.6% |
| 2015 | -$3.44M | +87.5% |
| 2014 | -$27.62M | +33.4% |
| 2013 | -$41.50M | -14.4% |
| 2012 | -$36.27M | -12.2% |
| 2011 | -$32.33M | -17.8% |
| 2010 | -$27.44M | -35.5% |
| 2009 | -$20.25M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $10.22M | -78.1% | -61.7% |
| June 30, 2025 | $26.68M | -25.1% | +680.9% |
| March 31, 2025 | $3.42M | -88.4% | -92.7% |
| September 30, 2024 | $46.60M | +49.5% | +30.9% |
| June 30, 2024 | $35.59M | +20.3% | +20.7% |
| March 31, 2024 | $29.50M | +98.6% | -5.4% |
| September 30, 2023 | $31.18M | -2.4% | +5.4% |
| June 30, 2023 | $29.58M | -5.9% | +99.2% |
- CORCEPT THERAPEUTICS INC showed a decrease of -67.3% in Operating Income compared to the prior fiscal year.
- Over the 2009–2025 period, CORCEPT THERAPEUTICS INC’s operating income has grown by 321.2% (from -$20.25 million to $44.80 million).
- The most recent figure is from CORCEPT THERAPEUTICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: